Medical treatment of endocarditis

被引：3

作者：

Abrutyn E. ^{[1
]}

Cabell C.H. ^{[1
]}

Fowler Jr. V.G. ^{[1
]}

Hoen B. ^{[1
]}

Miro J.M. ^{[1
]}

Mestres C.A. ^{[1
]}

Sexton D.J. ^{[1
]}

Corey G.R. ^{[1
]}

机构：

[1] Duke Clinical Research Institute, DUMC, Durham, NC 27710

来源：

Current Infectious Disease Reports | 2007年 / 9卷 / 4期

关键词：

Vancomycin; Endocarditis; Infective Endocarditis; Linezolid; Daptomycin;

D O I：

10.1007/s11908-007-0043-y

中图分类号：

学科分类号：

摘要：

Infective endocarditis (IE) remains a serious and deadly disease. The incidence, which varies by gender and on the presence of predisposing factors, has not decreased, due in part to the aging population with more healthcare exposures and predisposing risk factors such as prosthetic heart valves and intracardiac devices. The most important aspects of treatment in IE hinge upon early diagnosis, microorganism identification with susceptibility testing, and early initiation of appropriate antibiotic therapy. In addition, echocardiographic imaging is critical for both diagnostic and prognostic purposes. Early evaluation for surgery should be considered. Once a therapeutic strategy is begun, careful attention to the clinical course is necessary to ensure appropriate response to therapy and to identify complications early. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：271 / 282

页数：11

共 74 条

[1]

Hogevik H., Olaison L., Andersson R., Et al., Epidemiologic aspects of infective endocarditis in an urban population, Medicine, 74, pp. 324-339, (1995)

[2]

Berlin J.A., Abrutyn E., Strom B.L., Et al., Incidence of infective endocarditis in the Delaware Valley, 1988-1990, Amer J Card, 76, pp. 933-936, (1995)

[3]

Delahaye F., Goulet V., Lacassin F., Et al., Characteristics of infective endocarditis in France 1991: A one year survey, Eur Heart J, 16, pp. 394-401, (1995)

[4]

Hoen B., Alla F., Selton-Suty C., Et al., Changing profile of infective endocarditis: Results of a 1-year survey in France, JAMA, 288, pp. 75-81, (2002)

[5]

Halperin S.D., Abrutyn E., Strom B.L., Infective endocarditis, Evidenced Based Infectious Disease, pp. 37-51, (2004)

[6]

Cabell C.H., Fowler Jr V.G., Engemann J.J., Et al., Endocarditis in the elderly

[7]

Incidence, surgery, and survival in 16,921 patients over 12 years, Circulation, 106, (2002)

[8]

Strom B.L., Abrutyn E., Berlin J.A., Et al., Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study, Ann Intern Med, 129, pp. 761-769, (1998)

[9]

Fang G., Keys T.F., Gentry L.O., Et al., Prosthetic valve endocarditis resulting from nosocomial bacteremia: A prospective multicenter study, Ann Intern Med, 119, pp. 560-567, (1993)

[10]

Friedman N.D., Kaye K.S., Stout J.E., Et al., Health-care associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections, Ann Intern Med, 137, pp. 791-797, (2002)

← 1 2 3 4 5 6 7 8 →